18.04.2017 • NewsDede WillamsInnovationSongwon

Songwon Opens Innovation Center in Korea

(c) Songwon
(c) Songwon

South Korean specialty chemicals manufacturer Songwon recently opened a new Technology Innovation Center at its Maeam site. The company said the 32,000 m² Korean facility, designed with future expansion in mind, is part of its drive to strengthen its position on the global specialty chemicals playing field and “take another key step forward in entering new business areas with high value and sophisticated technology.”

The new center housing analysis labs, synthetic rooms, clean rooms, kilos lab scale rooms, polymer processing and application labs is aimed at supporting R&D, Global Application Community and Technical Service, leveraging synergies between the groups. It also will help consolidate the company’s technologies and support the development of new products from design phase to final customer applications, Songwon said, adding that this underscores its efforts to translate market needs into innovative product solutions quickly and efficiently.

Commenting on the investment, DK Park, Leader Research & Development said: “The new Technology Innovation Center will play a major role in securing a sustainable future for Songwon. It will drive real innovation and help us to advance along our path of producing high end fine chemistry.”

Company

Logo:

Songwon International AG

Breitenstrasse 16
8501 Frauenfeld
Switzerland

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.